The COVID-19 pandemic caused by SARS-CoV-2 is associated with a lower fatality rate
than its SARS and MERS counterparts. However, the rapid evolution of SARS-CoV-2 has …

Since the emergence of SARS-CoV-2, vaccines targeting COVID-19 have been developed
with unprecedented speed and efficiency. CoronaVac, utilising an inactivated form of the …

Rapid and accurate measurement of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …

To explore the effects of SARS-CoV-2-mRNA vaccines on innate immune responses we
enrolled 58 individuals who received 3 doses of the BNT162b2 vaccine in a longitudinal …

COVID-19 pandemic witnessed rapid development and use of several vaccines. In India, a
country-wide immunization was initiated in January 2021. COVISHIELD, the chimpanzee …

Neutralizing antibodies (NAbs) can be indicators of collective immunity, vaccine efficacy,
and the longevity of the humoral response. This study aimed to compare reactogenicity and …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) led to a global health
outbreak known as the COVID-19 pandemic which has been lasting since March 2020 …

Introduction Severe acute respiratory syndrome virus 2 (SARS-CoV-2) has caused over
million deaths worldwide, with more than 61,000 deaths in Chile. The Chilean government …

The adsorbed vaccine SARS-CoV-2 (inactivated) produced by Sinovac (SV) was the first
vaccine against COVID-19 to be used in Brazil. To understand the metabolic effects of SV in …

Several vaccines have been fast-tracked through clinical trials to mitigate the progression of
the SARS‑CoV‑2 pandemic. We analyzed sequential blood samples from 314 recipients of …